MALARIA RESEARCH INSTITUTE
Leading Science for a Malaria-Free World
Founded in May 2001 and continuously supported by Bloomberg Philanthropies, the Johns Hopkins Malaria Research Institute conducts discovery research at the Bloomberg School of Public Health in Baltimore and field research at the Macha Research Trust in Zambia and other sites of endemic malaria in sub-Saharan Africa, India, and elsewhere.
The initial Bloomberg Philanthropies gift established a state-of-the-art research facility with the goal to treat and control malaria, develop a vaccine, and find new drug targets and innovative strategies to prevent and cure the deadly disease. The Institute has contributed to advances in all these areas and is one of the most comprehensive research endeavors focused on malaria globally.
News and Noteworthy
In the News
As US faces rare EEE cases, which mosquito-borne diseases are rising in Europe? Matt Ippolito, MD, is quoted.
In the News
What to Know About Growing Cases of Viruses From Mosquitoes. David Sullivan, MD, is quoted.
Newly Published
Diversity and selection analyses identify transmission-blocking antigens as the optimal vaccine candidates in Plasmodium falciparum | Moss Lab
Newly Published
Anopheles gambiae lacking AgTRIO probe inefficiently on a mammalian host | Dimopoulos Lab
Newly Published
The major surface protein of malaria sporozoites is GPI-anchored to the plasma membrane | Sinnis Lab
130+
Pilot grants awarded
750+
First- and last-authored publications since 2010